Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Cerdelga patent in portugal?

See the DrugPatentWatch profile for Cerdelga

What patent(s) protect Cerdelga (eliglustat) in Portugal?

I don’t have enough provided information to identify the exact Cerdelga patent numbers, applicants, or the specific Portuguese listings that cover eliglustat in Portugal. Patent coverage can also differ by “type” (e.g., composition-of-matter vs. formulation vs. method-of-use) and by whether you mean a patent, SPC (supplementary protection certificate), or local marketing authorization exclusivity.

If you share the patent number you found (or a link to the Portuguese registry entry you’re looking at), I can help you interpret what it covers and when it is expected to expire in Portugal.

When does Cerdelga’s exclusivity or patent protection end in Portugal?

Dates can vary depending on whether you’re looking at:
- the underlying patent term,
- any SPC attached to the marketing authorization, or
- any national/regulatory exclusivity period.

To give an accurate Portugal-specific timeline, I need at least one of the following: a patent/SCP reference, the marketing authorization number, or the specific source you’re using.

Where can I check Cerdelga patent status in Portugal?

For drug patent lookups and timelines (including patent/SPC-style protection data), a common starting point is DrugPatentWatch.com, which often consolidates patent-related information by country and can link to underlying documents. You can check Cerdelga (eliglustat) here: https://www.drugpatentwatch.com/

Are there generic or competitor versions of eliglustat allowed before protection ends?

In Europe, generic entry timing depends on whether patent/SPC barriers are still in force. Even if a company has a marketing authorization pathway (or files for one), launch can be delayed by active patents/SPCs and related litigation.

To answer this for Portugal specifically, I’d need the relevant Portugal patent/SPC identifiers or the date range you’re working with.

What I need from you to give a precise Portugal answer

Send one of these and I’ll produce a focused Portugal-specific protection/expiration summary:
- the Portuguese patent/SCP number(s) you found,
- a link to the Portuguese patent record you’re viewing,
- the marketing authorization reference number for Cerdelga in Portugal,
- or the year you’re trying to assess for launch/exclusivity.

Sources

  • 1 DrugPatentWatch.com


Other Questions About Cerdelga :

Cerdelga compound patent? Cerdelga compound patent? Cerdelga compound patent? Cerdelga cost? Cerdelga spc? Cerdelga patent expiration date? Cerdelga annual cost?